Cancer-related fatigue (review).

Marcello Tavio, Isabella Milan, Umberto Tirelli

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Fatigue is one of the most common complaints of people with cancer. It affects the majority of patients actively undergoing cancer related therapies, but also a meaningful number of those who successfully completed therapy and are disease-free and potentially cured at the end of the treatments. In cancer setting, fatigue is to be defined as a chronic form of tiredness, which is perceived by the patient as being unusual or abnormal, and absolutely disproportionate with respect to the amount of exercise or activity he/she has carried out and which is not removed by resting or sleeping. The exact cause of fatigue is not known. In cancer setting there are many contributing or associated factors, such as cancer itself, cancer treatment (chemotherapy, radiation therapy, immunotherapy and surgery), depression or anxiety, some medications, pain, nausea, vomiting or diarrhea, poor nutrition, anemia, infections, insomnia. There is no standard of care for the assessment or treatment of fatigue in patients with cancer. The evaluation of fatigue is intrinsically multidimensional, even though the lack of objective measurement methods makes it difficult to draw up worldwide-accepted guidelines; nonetheless, a number of methods have been developed to assess it. Treatment of fatigue should depend on its cause, but presently it is still addressed against the associated symptoms rather than fatigue itself. Useful approaches includes erythropoietin alpha, psychostimulants, medications to treat pain, depression, nausea and difficult sleeping, physical therapy for reconditioning exercises or energy saving techniques, health education. In this report some of the crucial issues related to fatigue in people with cancer are reviewed.

Original languageEnglish
Pages (from-to)1093-1099
Number of pages7
JournalInternational Journal of Oncology
Volume21
Issue number5
Publication statusPublished - Nov 2002

Fingerprint

Fatigue
Neoplasms
Nausea
Depression
Therapeutics
Exercise Therapy
Pain
Second Primary Neoplasms
Sleep Initiation and Maintenance Disorders
Standard of Care
Erythropoietin
Health Education
Immunotherapy
Vomiting
Anemia
Diarrhea
Radiotherapy
Anxiety
Guidelines
Exercise

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tavio, M., Milan, I., & Tirelli, U. (2002). Cancer-related fatigue (review). International Journal of Oncology, 21(5), 1093-1099.

Cancer-related fatigue (review). / Tavio, Marcello; Milan, Isabella; Tirelli, Umberto.

In: International Journal of Oncology, Vol. 21, No. 5, 11.2002, p. 1093-1099.

Research output: Contribution to journalArticle

Tavio, M, Milan, I & Tirelli, U 2002, 'Cancer-related fatigue (review).', International Journal of Oncology, vol. 21, no. 5, pp. 1093-1099.
Tavio M, Milan I, Tirelli U. Cancer-related fatigue (review). International Journal of Oncology. 2002 Nov;21(5):1093-1099.
Tavio, Marcello ; Milan, Isabella ; Tirelli, Umberto. / Cancer-related fatigue (review). In: International Journal of Oncology. 2002 ; Vol. 21, No. 5. pp. 1093-1099.
@article{e53fc6bddb4f48728ded3229f52fd4fb,
title = "Cancer-related fatigue (review).",
abstract = "Fatigue is one of the most common complaints of people with cancer. It affects the majority of patients actively undergoing cancer related therapies, but also a meaningful number of those who successfully completed therapy and are disease-free and potentially cured at the end of the treatments. In cancer setting, fatigue is to be defined as a chronic form of tiredness, which is perceived by the patient as being unusual or abnormal, and absolutely disproportionate with respect to the amount of exercise or activity he/she has carried out and which is not removed by resting or sleeping. The exact cause of fatigue is not known. In cancer setting there are many contributing or associated factors, such as cancer itself, cancer treatment (chemotherapy, radiation therapy, immunotherapy and surgery), depression or anxiety, some medications, pain, nausea, vomiting or diarrhea, poor nutrition, anemia, infections, insomnia. There is no standard of care for the assessment or treatment of fatigue in patients with cancer. The evaluation of fatigue is intrinsically multidimensional, even though the lack of objective measurement methods makes it difficult to draw up worldwide-accepted guidelines; nonetheless, a number of methods have been developed to assess it. Treatment of fatigue should depend on its cause, but presently it is still addressed against the associated symptoms rather than fatigue itself. Useful approaches includes erythropoietin alpha, psychostimulants, medications to treat pain, depression, nausea and difficult sleeping, physical therapy for reconditioning exercises or energy saving techniques, health education. In this report some of the crucial issues related to fatigue in people with cancer are reviewed.",
author = "Marcello Tavio and Isabella Milan and Umberto Tirelli",
year = "2002",
month = "11",
language = "English",
volume = "21",
pages = "1093--1099",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Cancer-related fatigue (review).

AU - Tavio, Marcello

AU - Milan, Isabella

AU - Tirelli, Umberto

PY - 2002/11

Y1 - 2002/11

N2 - Fatigue is one of the most common complaints of people with cancer. It affects the majority of patients actively undergoing cancer related therapies, but also a meaningful number of those who successfully completed therapy and are disease-free and potentially cured at the end of the treatments. In cancer setting, fatigue is to be defined as a chronic form of tiredness, which is perceived by the patient as being unusual or abnormal, and absolutely disproportionate with respect to the amount of exercise or activity he/she has carried out and which is not removed by resting or sleeping. The exact cause of fatigue is not known. In cancer setting there are many contributing or associated factors, such as cancer itself, cancer treatment (chemotherapy, radiation therapy, immunotherapy and surgery), depression or anxiety, some medications, pain, nausea, vomiting or diarrhea, poor nutrition, anemia, infections, insomnia. There is no standard of care for the assessment or treatment of fatigue in patients with cancer. The evaluation of fatigue is intrinsically multidimensional, even though the lack of objective measurement methods makes it difficult to draw up worldwide-accepted guidelines; nonetheless, a number of methods have been developed to assess it. Treatment of fatigue should depend on its cause, but presently it is still addressed against the associated symptoms rather than fatigue itself. Useful approaches includes erythropoietin alpha, psychostimulants, medications to treat pain, depression, nausea and difficult sleeping, physical therapy for reconditioning exercises or energy saving techniques, health education. In this report some of the crucial issues related to fatigue in people with cancer are reviewed.

AB - Fatigue is one of the most common complaints of people with cancer. It affects the majority of patients actively undergoing cancer related therapies, but also a meaningful number of those who successfully completed therapy and are disease-free and potentially cured at the end of the treatments. In cancer setting, fatigue is to be defined as a chronic form of tiredness, which is perceived by the patient as being unusual or abnormal, and absolutely disproportionate with respect to the amount of exercise or activity he/she has carried out and which is not removed by resting or sleeping. The exact cause of fatigue is not known. In cancer setting there are many contributing or associated factors, such as cancer itself, cancer treatment (chemotherapy, radiation therapy, immunotherapy and surgery), depression or anxiety, some medications, pain, nausea, vomiting or diarrhea, poor nutrition, anemia, infections, insomnia. There is no standard of care for the assessment or treatment of fatigue in patients with cancer. The evaluation of fatigue is intrinsically multidimensional, even though the lack of objective measurement methods makes it difficult to draw up worldwide-accepted guidelines; nonetheless, a number of methods have been developed to assess it. Treatment of fatigue should depend on its cause, but presently it is still addressed against the associated symptoms rather than fatigue itself. Useful approaches includes erythropoietin alpha, psychostimulants, medications to treat pain, depression, nausea and difficult sleeping, physical therapy for reconditioning exercises or energy saving techniques, health education. In this report some of the crucial issues related to fatigue in people with cancer are reviewed.

UR - http://www.scopus.com/inward/record.url?scp=0036836147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036836147&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 1093

EP - 1099

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 5

ER -